Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 5601 - 5608 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN3733 | 4-Galloylquinic acid |
|
1. 4-Galloylquinic acid shows some antioxidative activity.
|
|
| BCN3734 | Digitonin |
|
1. Digitonin alone and together with the set of secondary metabolites (SM) , can mediate MDR reversal in cancer cells.
2. Digitonin solubilizes mitochondrial membrane, breaks the integrity of the respiratory chain and releases two mobile redox-active components: coenzyme Q (CoQ) and cytochrome c (cyt c). |
|
| BCN3735 | Sappanol |
|
1. Sappanol inhibits lipid peroxidation in a concentration-dependent manner, can significantly attenuated H2O2-induced retinal death, can be potential antioxidant treatment for retinal diseases.
|
|
| BCN3736 | 3-Deoxysappanchalcone |
|
1. 3-Deoxysappanchalcone is an effective HO-1 inducer at the translational level.
2. 3-Deoxysappanchalcone has anti-inflammatory effects, is a valuable compound for modulating inflammatory conditions. 3. 3-Deoxysappanchalcone has anti-influenza virus activity, the mechanism involved anti-apoptosis and anti-inflammation activities in vitro. 4. 3-Deoxysappanchalcone has inhibitory activity on MMP-9 expression and production in TNF-α-treated cells, is mediated by the suppression of AP-1 and NF-κB activation. |
|
| BCN3738 | Eriosemation |
|
1. Eriosemation significant androgen receptor (AR) inhibition activity, suggests that
it could be a promising candidate for further evaluation for prostate cancer prevention or management. |
|
| BCN3739 | Peroxydehydrotumulosic acid |
|
1. 5alpha,8alpha-Peroxydehydrotumulosic acid exhibits inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells.
|
|
| BCN3740 | Dehydrotumulosic acid |
|
1. Dehydrotumulosic acid shows anti-inflammatory activity.
|
|
| BCN3741 | Poricoic acid A(F) |
|
1. Poricoic acid A(F) shows anti-inflammatory activity.
|
|